GLP-1 basics
Scope: Semaglutide, tirzepatide, side effects, cost, compounded access, clinician questions
Refresh weekly while labels, shortages, and access rules move.
Operating plan · Content pipeline
What gets built next,
and why.
A living content plan for expanding The Glow Diary into a topical trust hub: more source-backed pages, better tools, stronger internal links, and metadata that helps Google understand the site without weakening medical boundaries.
01
Topic clusters
Build authority through coherent hubs, not one-off AI articles.
Next-gen pipeline
Scope: Retatrutide, CagriSema, amycretin, orforglipron, mazdutide, pemvidutide, survodutide
Build watchlist pages first; convert to full guides when peer-reviewed or regulatory milestones land.
Maintenance
Scope: Plateaus, stopping/pausing, regain, protein, strength training, nutrition friction, dose de-escalation
High-trust cluster because readers need help after the first prescription.
Peptide evidence
Scope: BPC-157, CJC/ipamorelin, sermorelin, tesamorelin, epitalon, polynucleotides
Separate approved narrow indications from wellness-market claims.
Aesthetic + hormones
Scope: Tretinoin, polynucleotides, HRT, perimenopause, skin-quality procedures
Expand only with source manifests and clear clinician boundaries.
Tools + validation
Scope: Comparison lab, cost estimator, safety explorer, nutrition planner, timeline simulator
Turn every guide into a question generator and data-backed utility.
02
Four-sprint roadmap
Practical sequence for content, tools, validation, and search.
Publish pipeline cluster
Oral GLP-1 guide, amylin/CagriSema guide, maintenance guide, expanded resources, sitemap/index verification.
Deep article batch
Orforglipron explainer, amycretin watchlist, MASH-metabolic crossover, maintenance-after-stopping, compounded safety update.
Tool upgrades
Add source chips per therapy, downloadable clinician checklist, compare-page FAQ schema, source-last-checked badges.
SEO + trust hardening
Article schema, breadcrumbs, llms.txt refresh, internal-link audit, image alt audit, GSC sitemap submission, content decay monitor.
03
SEO metadata queue
High-intent pages to map to titles, descriptions, internal links, and schema.
glp-1 side effects timelinesemaglutide vs tirzepatideorforglipron oral glp-1cagrisema vs tirzepatideamycretin weight lossretatrutide pipelineglp-1 maintenance after stoppingprotein on glp-1compounded semaglutide safetybpc-157 evidence
Validation checklist before publishing a batch
- Every medical or therapy claim traces to FDA labels, PubMed, ClinicalTrials.gov, NIH/NIDDK, MedlinePlus, or an explicitly labeled lower-tier source.
- Every page has a unique title, description, canonical URL, Open Graph image, and internal links to at least two related pages.
- Pipeline pages avoid consumer access guidance and clearly label investigational status.
- Tools stay education-only and avoid recommendations, dosing protocols, personalized predictions, or sponsor claims.
- Sitemap, robots.txt, feed.xml, llms.txt, and live browser smoke tests are checked after deployment.